Proprotein convertase subtilisin/kexin type 9 (PCSK9): A potential multifaceted player in cancer.

Bhattacharya, Anindita; Chowdhury, Abhirup; Chaudhury, Koel; Shukla, Praphulla Chandra

Bhattacharya, Anindita; Chowdhury, Abhirup; Chaudhury, Koel; Shukla, Praphulla Chandra.

Afiliación

Bhattacharya A; School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur 721302, India.
Chowdhury A; School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur 721302, India.
Chaudhury K; School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur 721302, India. Electronic address: koel@smst.iitkgp.ac.in.
Shukla PC; School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur 721302, India. Electronic address: pcshukla@smst.iitkgp.ac.in.

Biochim Biophys Acta Rev Cancer ; 1876(1): 188581, 2021 08.

Article en En | MEDLINE | ID: mdl-34144130

Asunto(s)

Neoplasias/enzimología; Proproteína Convertasa 9/metabolismo; Animales; Antineoplásicos/uso terapéutico; Apoptosis; Movimiento Celular; Proliferación Celular; Regulación Neoplásica de la Expresión Génica; Humanos; Terapia Molecular Dirigida; Invasividad Neoplásica; Metástasis de la Neoplasia; Neoplasias/tratamiento farmacológico; Neoplasias/genética; Neoplasias/patología; Inhibidores de PCSK9; Proproteína Convertasa 9/genética; Inhibidores de Serina Proteinasa/uso terapéutico; Transducción de Señal

Palabras clave

Anti-tumor immunity; Apoptosis; Cancer; Metastasis; PCSK9; Targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Proproteína Convertasa 9 / Neoplasias Tipo de estudio: Prognostic_studies Idioma: En Revista: Biochim Biophys Acta Rev Cancer Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google